Verified Nov 2026
Other
·

Philadelphia, Pennsylvania
·
Since 1967
PCI Pharma Services is a contract development and manufacturing organization (CDMO) headquartered in Philadelphia, Pennsylvania, founded in 1967. The company employs 5,000 to 10,000 people and generates estimated revenue between $500 million and $1 billion. It operates 38 GMP-certified facilities across seven countries, offering drug development, sterile manufacturing, clinical trial services, and commercial packaging for small molecule drugs, biologics, and high-potency compounds served to pharmaceutical and biotech clients in over 100 countries. Recent expansions include a ramped sterile manufacturing operation at its Bedford campus and a drug substance facility expansion in San Diego.
PCI Pharma Services at a glance
Revenue
$500M-1B
Est. band
Employees
5,000-10,000
Founded
1967
Headquarters
Philadelphia, Pennsylvania
Import activity
63
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
63
Named foreign suppliers
34
Top origins
Singapore · Germany · Belgium · Netherlands

Shared foreign counterparties do not establish that these companies buy from PCI Pharma Services.
What this tells a buyer
PCI received over 4,500 inbound shipments across its record, with major suppliers including Fresenius Kabi Norge (Norway, 1,975 shipments), Schott Schweiz (Switzerland, 830 shipments), and MSD International (Singapore, 272 shipments), reflecting a global procurement footprint.
The company provides sterile fill-finish manufacturing, lyophilization services, analytical development and testing, aseptic formulation, complex process engineering, and quality person (QP) services across its facility network.
PCI is privately held and has received investments exceeding $1 billion to support growth and facility expansions.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
59 years in operation (founded 1967).
63 US import shipments on record.
Overview
PCI Pharma Services is a contract development and manufacturing organization (CDMO) headquartered in Philadelphia, Pennsylvania, founded in 1967. The company employs 5,000 to 10,000 people and generates estimated revenue between $500 million and $1 billion. It operates 38 GMP-certified facilities across seven countries, offering drug development, sterile manufacturing, clinical trial services, and commercial packaging for small molecule drugs, biologics, and high-potency compounds served to pharmaceutical and biotech clients in over 100 countries. Recent expansions include a ramped sterile manufacturing operation at its Bedford campus and a drug substance facility expansion in San Diego.
At a glance
Attribute | Detail |
|---|---|
Founded | 1967 |
Headquarters | Philadelphia, Pennsylvania |
Employees | 5,000-10,000 |
Revenue | $500M-1B (estimated) |
What PCI Pharma Services makes
The company provides sterile fill-finish manufacturing, lyophilization services, analytical development and testing, aseptic formulation, complex process engineering, and quality person (QP) services across its facility network.
Products and capabilities described on the company's own site include Assembly, LED (source: pci.com).
Trade and customs footprint
PCI received over 4,500 inbound shipments across its record, with major suppliers including Fresenius Kabi Norge (Norway, 1,975 shipments), Schott Schweiz (Switzerland, 830 shipments), and MSD International (Singapore, 272 shipments), reflecting a global procurement footprint. US customs bill-of-lading records list 63 inbound shipments across 34 foreign suppliers, with top origins including Singapore · Germany · Belgium · Netherlands.
Latest developments
2026-10-19 — PCI Pharma Services' Expanded Bedford Campus Ramps Up Sterile Manufacturing | High-Profile Monthly (high-profile.com)
2026-05-29 — Pci Pharma Drug Substance Manufacturing Facility Expansion San Diego US (pharmaceutical-technology.com)
2026-04-27 — Backed by Investments Exceeding $1 Billion, PCI Pharma Services… | PCI (pci.com)
2025-11-27 — Global CDMO News / PCI / Let's talk future | PCI (pci.com)
2025-07-14 — PCI Pharma Services Enters Next Phase of Growth With Strategic… | PCI (pci.com)
2025-07-08 — PCI Pharma Services to expand along Alpine and Linden roads in south Rockford - Rock River Current (rockrivercurrent.com)
Company details
PCI is privately held and has received investments exceeding $1 billion to support growth and facility expansions. PCI Pharma Services was founded in 1967, has an estimated 5,000-10,000 employees, and is headquartered in Philadelphia, Pennsylvania. On the LightSource stability read it is rated "Established & active": 59 years in operation (founded 1967). 63 US import shipments on record.
Frequently asked questions
What does PCI Pharma Services do?
PCI Pharma Services is a contract development and manufacturing organization (CDMO) headquartered in Philadelphia, Pennsylvania, founded in 1967. The company employs 5,000 to 10,000 people and generates estimated revenue between $500 million and $1 billion. It operates 38 GMP-certified facilities across seven countries, offering drug development, sterile manufacturing, clinical trial services, and commercial packaging for small molecule drugs, biologics, and high-potency compounds served to pharmaceutical and biotech clients in over 100 countries. Recent expansions include a ramped sterile manufacturing operation at its Bedford campus and a drug substance facility expansion in San Diego.
Where is PCI Pharma Services headquartered?
PCI Pharma Services is headquartered in Philadelphia, Pennsylvania (3001 Red Lion Road, Philadelphia, Pennsylvania, 19114).
When was PCI Pharma Services founded?
PCI Pharma Services was founded in 1967.
How big is PCI Pharma Services?
PCI Pharma Services has an estimated 5,000-10,000 employees, with revenue in the $500M-1B range (estimated).
Does PCI Pharma Services import from overseas suppliers?
US customs bill-of-lading records show 63 inbound shipments for PCI Pharma Services, with top origins including Singapore · Germany · Belgium · Netherlands.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
